ICLR

ICON plc
D

ICLR

142.920
USD
-2.15
(-1.48%)
مغلق
حجم التداول
111,052
الربح لكل سهم
14
العائد الربحي
-
P/E
16
حجم السوق
11,550,902,590
أصول ذات صلة
NEOUSD
NEOUSD
-0.08928
(-1.54%)
5.70815 USD
B
BIO
-4.000
(-1.66%)
236.340 USD
C
CRL
1.560
(1.34%)
118.410 USD
DGX
DGX
0.630
(0.36%)
178.000 USD
ILMN
ILMN
1.395
(1.82%)
77.905 USD
LH
LH
6.300
(2.61%)
247.700 USD
MTD
MTD
44.40
(4.20%)
1,100.79 USD
N
NEO
0.46000
(6.34%)
7.72000 USD
Q
QDEL
1.270
(4.56%)
29.140 USD
TMO
TMO
3.67
(0.87%)
423.51 USD
WST
WST
2.485
(1.19%)
211.275 USD
المزيد
الأخبار المقالات

العنوان: ICON plc

القطاع: Healthcare
الصناعة: Diagnostics & Research
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.